Clinical Outcomes of Magnesium Sulfate in Cervical Interlaminar Epidural Steroid Injection
Active, not recruitingNCT07788820
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This observational study will compare the clinical outcomes of two cervical interlaminar epidural steroid injection protocols used in routine clinical practice for adults with chronic cervical radicular pain caused by cervical disc herniation. One group received lidocaine, dexamethasone, and normal saline, while the other group received lidocaine, dexamethasone, and magnesium sulfate. Pain intensity, neck-related disability, and health-related quality of life will be evaluated using the Numeric Rating Scale, Neck Disability Index, and Short Form-12. Outcomes will be assessed before the procedure and at routine follow-up visits up to three months after the procedure. Treatment selection was based on routine clinical decisions and was not assigned by the researchers. No additional medication, procedure, test, or follow-up visit will be performed for the purposes of this study. The study uses data from existing medical records and routine clinical follow-up assessments.
Study details
- Official title
- Clinical Outcomes of Magnesium Sulfate Use in Cervical Interlaminar Epidural Steroid Injection for Chronic Cervical Radicular Pain: A Comparative Observational Cohort Study
- Conditions
- Cervical Radiculopathy
- Cervical Disc Herniation
- Interventions
- Sponsor
- Marmara University
- Start date
- 2026-01-01
- Primary completion
- 2026-10
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 18 to 75 years * Diagnosis of cervical disc herniation associated with chronic cervical radicular pain * Underwent cervical interlaminar epidural steroid injection * Availability of pre-procedure and 1-hour post-procedure Numeric Rating Scale scores * Availability of baseline and 3-week Neck Disability Index and Short Form-12 assessments * Availability of the 3-month routine follow-up assessment * Documented injection protocol: standard protocol or magnesium sulfate-containing protocol Exclusion Criteria: * Cervical pain primarily attributable to a condition other than cervical radiculopathy * Previous cervical spine surgery * Cervical pain associated with malignancy, infection, trauma, or inflammatory disease * Advanced neurological deficit or clinical findings of myelopathy * Receipt of another interventional pain procedure during the same follow-up period * Missing pre-procedure or 1-hour post-procedure Numeric Rating Scale data * Missing baseline, 3-week, or 3-month Neck Disability Index or Short Form-12 data * Unavailable or inadequately documented injection content or treatment protocol
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07788820